ANIP
HEALTHCAREANI Pharmaceuticals Inc
AI Insight
What's Moving ANIP Today?
No stock-specific AI insight has been generated for ANIP yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$62.60$99.50
$82.94
Fundamentals
Market Cap$1.8B
P/E Ratio20.6
EPS$3.91
Dividend Yield—
Dividend / Share—
ROE18.3%
Profit Margin10.0%
Debt / Equity—
Trading
Volume378K
Avg Volume (10D)—
Shares Outstanding22.7M
ANIP News
26 articles- ANI Pharmaceuticals Inc (ANIP) Earnings Forecast: Future EPS & Revenue Growth EstimatesTradingKey·Jun 18, 2026
- Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?Yahoo Finance·Jun 10, 2026
- ANI Pharmaceuticals Targets Acute Gout With Cortrophin PushYahoo Finance·Jun 10, 2026
- Ani Pharmaceuticals SVP & CFO Stephen Carey sells $264,960 in stockInvesting.com Australia·Jun 10, 2026
- 2 Cash-Producing Stocks to Research Further and 1 Facing ChallengesYahoo Finance·Jun 9, 2026
- How ANI’s Estradiol Gel Recall at ANI Pharmaceuticals (ANIP) Has Changed Its Quality-Control Investment StoryYahoo Finance·Jun 5, 2026
- Ani (ANIP) Q1 2026 Earnings Call TranscriptMotley Fool·Jun 1, 2026
- 2 Growth Stocks with Explosive Upside and 1 We AvoidYahoo Finance·May 29, 2026
- ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare ConferenceYahoo Finance·May 27, 2026
- ANI Pharmaceuticals raises 2026 revenue outlook to $1.08B-$1.14B while launching $100M share repurchase programMSN·May 24, 2026
- ANI Pharmaceuticals (NASDAQ: ANIP) investors back directors, pay and stock planStock Titan·May 22, 2026
- Q1 Earnings Outperformers: ANI Pharmaceuticals (NASDAQ:ANIP) And The Rest Of The Pharmaceuticals StocksYahoo Finance·May 21, 2026
- ANI Pharmaceuticals' (NASDAQ:ANIP) Earnings Are Weaker Than They SeemYahoo Finance·May 19, 2026
- 2 Profitable Stocks with Competitive Advantages and 1 Facing HeadwindsYahoo Finance·May 18, 2026
- How Raised 2026 Guidance And A New Buyback At ANI Pharmaceuticals (ANIP) Has Changed Its Investment StoryYahoo Finance·May 17, 2026
- ANI Pharmaceuticals Refocuses On Rare Disease As Buybacks And Insider Sales RiseYahoo Finance·May 17, 2026
- ANI Pharmaceuticals: Rare Disease Shift and the 2026 PlaybookYahoo Finance·May 15, 2026
- [144] ANI PHARMACEUTICALS INC SEC FilingStock Titan·May 11, 2026
- Global Alpha Dumps 229,000 Ani Pharmaceuticals (ANIP) Shares Worth $17.9 MillionMotley Fool·May 11, 2026
- ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook RaisedYahoo Finance·May 11, 2026
- Zacks.com featured highlights include ANI, Cummins and SeadrillYahoo Finance·May 11, 2026
- Is ANI Pharmaceuticals (ANIP) Still Attractively Priced After Recent Pipeline Developments?Yahoo Finance·May 9, 2026
- ANI Pharmaceuticals Inc (ANIP) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...Yahoo Finance·May 9, 2026
- ANI Pharmaceuticals, Inc. (ANIP): A Small Cap Value Stock Capitalizing on Generic Drugs OpportunitiesYahoo Finance·May 8, 2026
- ANI Pharmaceuticals Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025The Motley Fool·Mar 27, 2026
All 26 articles loaded
Price Data
Open$81.31
Previous Close$80.58
Day High$83.31
Day Low$80.62
52 Week High$99.50
52 Week Low$62.60
52-Week Range
$62.60$99.50
$82.94
Fundamentals
Market Cap$1.8B
P/E Ratio20.6
EPS$3.91
Dividend Yield—
Dividend / Share—
ROE18.3%
Profit Margin10.0%
Debt / Equity—
Trading
Volume378K
Avg Volume (10D)—
Shares Outstanding22.7M
About ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—